Suppr超能文献

日本传统汉方药物Boi-Ogi-To通过激活容积敏感性外向整流阴离子通道促进细胞内氯离子和水的排泄。

Boi-Ogi-To, a Traditional Japanese Kampo Medicine, Promotes Cellular Excretion of Chloride and Water by Activating Volume-Sensitive Outwardly Rectifying Anion Channels.

作者信息

Sato-Numata Kaori, Suzuki Taro, Saito Haruna, Kato Shotaro, Sakai Ayako, Mori Shuntaro, Nakae Hajime, Hasegawa Hitoshi, Okada Yasunobu, Numata Tomohiro

机构信息

Department of Integrative Physiology, Graduate School of Medicine, Akita University, Akita, Japan.

School of Medicine, Akita University, Akita, Japan.

出版信息

FASEB J. 2025 May 15;39(9):e70573. doi: 10.1096/fj.202403278R.

Abstract

The Japanese Kampo medicine Boi-ogi-to (BOT) is known as an effective therapeutic agent for edema and nephrosis by promoting the excretion of excess body fluids. Despite its empirical effectiveness, scientific evidence supporting its effectiveness remains limited. In this study, we conducted a retrospective study of the effects of BOT administration on the blood test values of patients before and after taking the drug to attempt translational research between basic science and daily clinical practice by focusing on the molecular mechanism of action of BOT in vitro. We found that blood sodium and chloride levels are higher after taking BOT by analyzing the clinical test values before and after taking the drug from 28 patients attending Akita University Hospital. In this light, we measured the cell volume of human embryonic kidney HEK293T cells in vitro in order to investigate the possibility that BOT induces Cl excretion and cell volume reduction. BOT showed concentration-dependent cell volume reduction with an EC of 686 μg/mL. The volume reduction effect was suppressed by the Cl channel inhibitors DIDS and DCPIB. Furthermore, patch-clamp studies showed that BOT-activated Cl currents exhibit outward rectification and time-dependent inactivation upon depolarization. These biophysical properties of BOT-induced Cl currents correspond to those of volume-sensitive outward rectifier (VSOR) anion channels. The Cl currents activated by the administration of BOT were inhibited by applying DIDS, DCPIB, and siRNA targeting the gene of LRRC8A, a core component of the VSOR channel, as well as in LRRC8-deficient cells. Additionally, BOT-induced Cl currents were restored by coexpression of LRRC8A/C in LRRC8-deficient cells. Also, BOT was found to translocate LRRC8A proteins to the plasma membrane. These results demonstrated that BOT activates LRRC8-containing VSOR channels by delivering LRRC8A to the plasma membrane and induces Cl release, thereby promoting water excretion.

摘要

日本汉方药物保乙奥剂(BOT)作为一种通过促进多余体液排泄来治疗水肿和肾病的有效药物而闻名。尽管其经验性疗效显著,但支持其有效性的科学证据仍然有限。在本研究中,我们进行了一项回顾性研究,通过关注BOT在体外的分子作用机制,来探讨服用BOT前后对患者血液检测值的影响,以尝试基础科学与日常临床实践之间的转化研究。通过分析秋田大学医院28例患者服药前后的临床检测值,我们发现服用BOT后血钠和血氯水平升高。鉴于此,我们在体外测量了人胚肾HEK293T细胞的细胞体积,以研究BOT诱导氯离子排泄和细胞体积减小的可能性。BOT呈现出浓度依赖性的细胞体积减小,半数有效浓度(EC)为686μg/mL。氯离子通道抑制剂DIDS和DCPIB可抑制这种体积减小效应。此外,膜片钳研究表明,BOT激活的氯离子电流在去极化时表现出外向整流和时间依赖性失活。BOT诱导的氯离子电流的这些生物物理特性与容积敏感性外向整流(VSOR)阴离子通道的特性一致。通过应用DIDS、DCPIB和靶向VSOR通道核心成分LRRC8A基因的小干扰RNA(siRNA),以及在LRRC8缺陷细胞中,均可抑制BOT给药激活的氯离子电流。此外,在LRRC8缺陷细胞中共表达LRRC8A/C可恢复BOT诱导的氯离子电流。同时,发现BOT可将LRRC8A蛋白转运至质膜。这些结果表明,BOT通过将LRRC8A转运至质膜来激活含LRRC8的VSOR通道,并诱导氯离子释放,从而促进水分排泄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ee/12059615/f8b7ac2c7685/FSB2-39-e70573-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验